SPTLC1 and amyotrophic lateral sclerosis: Elimination of SPTLC1 mutants can reduce accumulation of putative toxic lipids [17], while reducing toxic lipids rescues cellular phenotypes [16], suggesting that lipid dysfunction could drive ALS pathogenesis.